InvestorsHub Logo
Followers 6
Posts 515
Boards Moderated 0
Alias Born 04/25/2010

Re: None

Wednesday, 09/11/2019 8:42:18 PM

Wednesday, September 11, 2019 8:42:18 PM

Post# of 428989
Question on AdCom procedures...

Per the AdCom notification letter, there is information regarding the process for the submission of public comments prior to the meeting.

It mentions 'confidential submissions'.
Just a general question...Why would confidential submissions be necessary? I thought the government wants transparency in these types of proceedings.

In regards to AMRN AdCom, would firms under BigPharma and Dietary Supplements, along with MRC avail themselves of this confidentiality provision? Possibly there is some proprietary process or info that the public commenter wishes to keep private for competitive reasons? (or keep their name out of the limelight in an attempt to derail Vascepa?)

If somebody is making adverse accusations against Vascepa, AMRN, and/or the Reduce-It trial parameters, I would think that the public has a right to know who is behind the accusations and if there may be a conflict of interests.

Just trying to understand the process...

Thanks in advance for replies.

Cheers!
Flubber
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News